Flex Pharma, Inc. logo

Flex Pharma, Inc.

Flex Pharma, Inc. is a biopharmaceutical company dedicated to creating innovative, novel treatments for neuromuscular disorders. Flex Pharma (NASDAQ:FLKS), is a biotechnology company, focuses on developing treatments for exercise-associated muscle cramps, nocturnal leg cramps, and spasms associated with neuromuscular conditions.

Flex Pharma is co-founded by Christoph H. Westphal along with National Academy of Science members Rod MacKinnon, M.D. (Nobel Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of ion channels and neurobiology.

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”FLKS” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.flex-pharma.com
Founded2014
Disease Focus
Development Stage
STOCK CODENASDAQ: FLKS
Address
800 Boylston St.24th Floor MA 02199
Boston
United States
Email
info@flex-pharma.com
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/flex-pharma” connections=”true” suffix=””]

In Jan 2015, Flex raised nearly $100 Mn in IPO through listing at NASDAQ. Prior that company received $40 Mn USD in its first round of funding. Key investors are Longwood Fund, Bessemer Venture Partners (BVP), EcoR1 Capital, Jennison Associates, Lightstone Ventures (LSV), Bindley Capital Partners (BCP), City Hill Ventures, LLC etc.